CIK 0000822370
- Non-accelerated filer
- Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870419387
- Phone
- +1 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- Open-market buys, last 90 days
- $15,026
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$15,026. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-03-03 | Hoffman Daniel A President and CMO | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2009-03-02 | Hoffman Daniel A Chief Medical Officer | Purchase | +500 | $0.79 | $395 | 500 |
| 2009-02-20 | Hoffman Daniel A Chief Medical Officer | Purchase | +477 | $0.79 | $377 | 98,521 |
| 2009-02-20 | Hoffman Daniel A Chief Medical Officer | Purchase | +23 | $0.80 | $18 | 98,544 |
Page 1 of 1 · 4 trades